DrugPatentWatch Database Preview
Janssen R And D Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for JANSSEN R AND D, and when can generic versions of JANSSEN R AND D drugs launch?
JANSSEN R AND D has two approved drugs.
There are four US patents protecting JANSSEN R AND D drugs.
There are one hundred and thirty-four patent family members on JANSSEN R AND D drugs in thirty-nine countries and twelve supplementary protection certificates in eleven countries.
Summary for Janssen R And D
| International Patents: | 134 |
| US Patents: | 4 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Janssen R And D
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-001 | Jan 18, 2008 | RX | Yes | No | Start Trial | Start Trial | |||||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | Start Trial | Start Trial | |||||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | 7,037,917*PED | Start Trial | Y | Start Trial | |||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-002 | Dec 22, 2010 | RX | Yes | Yes | 7,887,845*PED | Start Trial | Y | Start Trial | |||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | 8,003,789*PED | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Janssen R And D
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | 7,887,845*PED | Start Trial |
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-002 | Dec 22, 2010 | 7,887,845*PED | Start Trial |
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-001 | Jan 18, 2008 | 7,887,845*PED | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Janssen R And D Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 005423 | Start Trial |
| Estonia | 200100252 | Start Trial |
| Slovenia | 1129079 | Start Trial |
| Portugal | 1129079 | Start Trial |
| Norway | 318801 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Janssen R And D Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1002795 | SZ 5/2009 | Austria | Start Trial | PRODUCT NAME: ETRAVIRIN UND DESSEN ADDITIONSSALZE |
| 1002795 | SPC033/2008 | Ireland | Start Trial | SPC033/2008: 20090914, EXPIRES: 20230827 |
| 1002795 | CA 2009 00004 | Denmark | Start Trial | |
| 1002795 | 91528 | Luxembourg | Start Trial | 91528, EXPIRES: 20230828 |
| 1002795 | 122009000003 | Germany | Start Trial | PRODUCT NAME: ETRAVIRIN UND DESSEN ADDITIONSSALZE; REGISTRATION NO/DATE: EU/1/08/468/001 20080828 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
